Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesMetabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants
Nutrition, Metabolism & Cardiovascular Diseases, 06/05/09
Ronconi V et al. – Data confirm a higher prevalence of metabolic syndrome among pts with primary aldosteronism (PA) vs matched essential hypertensive (EH) pts. Genetic analysis of T45G and G276T adiponectin gene polymorphisms showed that, genotypes 45G/G+G/T have a protective role on metabolic complications, but the genotype 276T/T defined PA and EH pts with a worse metabolic profile.
Methods- Study of whether metabolic syndrome represents a common feature in PA pts vs EH pts
- Study of the impact of 2 common adiponectin gene variants on parameters of metabolic syndrome
- Metabolic syndrome defined by ATPIII criteria
- Subjects: 89 PA pts; 164 matched EH pts
- Detection of 2 adiponectin gene single nucleotide polymorphisms, T45G and G276T, in all PA pts and in 135 EH pts
- PA pts had higher prevalence of metabolic syndrome vs EH pts (45% vs 30)
- In PA pts, genotypes 45T/G+G/G associated with significantly lower values of waist circumference, HOMA-IR and serum aldosterone
- In both PA pts and EH pts, 276T/T genotype associated with significantly worse metabolic profile and a higher risk for the metabolic syndrome
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Arthritis Care and Research , 11/03/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Practical strategies for management of hypertension in the elderly
Geriatrics, 10/21/09
Sponsor
Article Search
Sponsor
Sponsor